Unique Liquid Chromatography Technique for Determining a New Selective PPARα Modulator Drug (Pemafibrate) in the Tablet Dosage Form, Robustness by Design Expert in the Light of Quality by Design
Biomedical Chromatography · 2025
DOI: 10.1002/bmc.70006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, 2025. Verfasst von Fei Han und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Biotechnology and Key Laboratory of Industrial Biotechnology of Ministry of Education, Jiangnan University, Wuxi, China. Hauptthemen laut MEDLINE: Benzoxazoles, Butyrates, PPAR alpha. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Abstract (Originalsprache)
This research study presents a precise, accurate, and linear liquid‐chromatography method for the determination of pemafibrate in tablet dosage forms, despite the presence of a high volume of excipients. Various challenges were addressed through experimental approaches and evidence‐based solutions. The method employs a suitable stationary phase, X‐Bridge C 18 (150 × 4.6 mm, 3.5 μm), and an appropriate isocratic program. Key parameters include a flow rate of 1.0 mL/min, a column temperature of 40°C, an injection volume of 10 μL, and a runtime of 15 min. The wavelength was set at 210 nm because of its high response. Mobile phase optimization, based on experimental results, consists of 0.1% H 3 PO 4 buffer and acetonitrile in a 40:60 v/v ratio. The method has been validated according to ICH Q2 (R2) and Ch. P guidelines, achieving a recovery rate of 99.1% to 100.5% at levels of 50%, 100%, and 150%. Linearity was demonstrated from 25% to 300% concentration levels, with a correlation coefficient ( r 2 ) value of 1.000. Precision results showed %RSD values of 1.0 and 1.1. Forced degradation studies indicated sensitivity to acid hydrolysis stress conditions and stability under physical stress conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biotechnology and Key Laboratory of Industrial Biotechnology of Ministry of Education, Jiangnan University, Wuxi, China.
- National Engineering Research Center of Cereal Fermentation and Food Biomanufacturing, Jiangnan University, Wuxi, China.
- Jiangsu Provincial Engineering Research Center for Bioactive Product Processing, Jiangnan University, Wuxi, China.
- R&D Department, Shanghai Aurora Biotechnology Co., Ltd, Shanghai, China.
- School of Biotechnology, Zhengzhou University of Technology, Zhengzhou, China.
- Quality Control Department, Aarkish Pharmaceuticals NJ INC, Fairfield, New Jersey, USA.
ORCID-Profile: Rathnakar Nathi, Naresh Konduru
Zitieren
APA
Han, F., Yang, Y., Bai, Z., Nathi, R., & Konduru, N. (2025). Unique Liquid Chromatography Technique for Determining a New Selective PPARα Modulator Drug (Pemafibrate) in the Tablet Dosage Form, Robustness by Design Expert in the Light of Quality by Design. Biomedical Chromatography. https://doi.org/10.1002/bmc.70006
Vancouver
Han F, Yang Y, Bai Z, Nathi R, Konduru N. Unique Liquid Chromatography Technique for Determining a New Selective PPARα Modulator Drug (Pemafibrate) in the Tablet Dosage Form, Robustness by Design Expert in the Light of Quality by Design. Biomedical Chromatography. 2025. doi:10.1002/bmc.70006
BibTeX
@article{Han2025,
author = {Han, Fei and Yang, Yankun and Bai, Zhonghu and Nathi, Rathnakar and Konduru, Naresh},
title = {Unique Liquid Chromatography Technique for Determining a New Selective PPARα Modulator Drug (Pemafibrate) in the Tablet Dosage Form, Robustness by Design Expert in the Light of Quality by Design},
journal = {Biomedical Chromatography},
year = {2025},
doi = {10.1002/bmc.70006}
}
EUVIMED